Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha.

Human endothelial cells respond to extracellular proteases, endotoxin (lipopolysaccharide, LPS), and inflammatory cytokines. Endothelial cells express several protease-activated receptors (PAR), including the thrombin-activated receptors PAR-1 and PAR-3 and a thrombin-independent, protease-activated receptor, PAR-2. To examine the potential cooperation between PAR and inflammatory stimuli, we investigated the effects of the PAR-1 agonist peptide Ser-Phe-Leu-Leu-Arg-Asn (SFLLRN) and PAR-2 agonist peptide Ser-Leu-Ile-Gly-Lys-Val (SLIGKV) on endothelial cells. Human umbilical vein endothelial cells (HUVEC) were cultured in vitro with SFLLRN or SLIGKV in the presence and absence of LPS or tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) levels in the culture supernatants were assayed. Both SFLLRN and SLIGKV induced detectable levels of IL-6 production in a dose-dependent fashion, with the PAR-1 receptor agonist being more potent. In the presence of all stimulatory concentrations of LPS or TNF-alpha tested, both peptides were found to further enhance IL-6 production. The effects of SFLLRN and SLIGKV were specific, as related peptides with identical amino acid compositions, but lacking in consensus sequences, were biologically inactive either alone or in the presence of LPS. Both the direct and the amplifying effects of PAR agonist peptides on IL-6 production were pertussis toxin sensitive and caused an increase in the intracellular levels of calcium, implicating G-proteins and calcium mobilization in these pathways. Furthermore, the amplifying effect of LPS or TNF-alpha on PAR-mediated cytokine production was associated with corresponding increases in nuclear NF-kappaB proteins. The results demonstrate significant potentiation of PAR-induced signaling by LPS and TNF-alpha and indicate the potential cooperation of proteases and inflammatory stimuli in amplifying vascular inflammation.

[1]  J. Wallace,et al.  Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. , 2002, The American journal of pathology.

[2]  T. Hammond,et al.  Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. , 2002, The American journal of pathology.

[3]  C. Stroh,et al.  Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. , 2002, The Journal of investigative dermatology.

[4]  D. Stechschulte,et al.  Endotoxin and mast cell granule proteases synergistically activate human coronary artery endothelial cells to generate interleukin-6 and interleukin-8. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[5]  T. Nakajima,et al.  Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-κB activation in synovial fibroblasts , 1999, Annals of the rheumatic diseases.

[6]  T. Suzuki,et al.  Transient degradation of NF-kappaB proteins in macrophages after interaction with mast cell granules. , 1998, Mediators of inflammation.

[7]  D. Stechschulte,et al.  Mast cell granules potentiate endotoxin‐induced interleukin‐6 production by endothelial cells , 1997, Journal of leukocyte biology.

[8]  P. Bongrand,et al.  Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression. , 1997, Journal of immunology.

[9]  Patricia Andrade-Gordon,et al.  Endothelial Cell Thrombin Receptors and PAR-2 , 1997, The Journal of Biological Chemistry.

[10]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[11]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[12]  S. Coughlin,et al.  Role of the Thrombin Receptor's Cytoplasmic Tail in Intracellular Trafficking , 1996, The Journal of Biological Chemistry.

[13]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[14]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[15]  S. Coughlin,et al.  The Cloned Thrombin Receptor Is Necessary and Sufficient for Activation of Mitogen-activated Protein Kinase and Mitogenesis in Mouse Lung Fibroblasts , 1996, The Journal of Biological Chemistry.

[16]  V. Ramakrishnan,et al.  The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial Cells , 1996, The Journal of Biological Chemistry.

[17]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[18]  T. Suzuki,et al.  The binding of immobilized IgG2a to Fc gamma 2a receptor activates NF-kappa B via reactive oxygen intermediates and tumor necrosis factor-alpha 1. , 1994, The Journal of biological chemistry.

[19]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[20]  U. Ikeda,et al.  Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. , 1994, Cytokine.

[21]  T. Suzuki,et al.  Influence of 3' half-site sequence of NF-kappa B motifs on the binding of lipopolysaccharide-activatable macrophage NF-kappa B proteins. , 1993, The Journal of biological chemistry.

[22]  T. Suzuki,et al.  Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). , 1993, The Journal of biological chemistry.

[23]  T. Suzuki,et al.  Role of protein kinase A in LPS-induced activation of NF-kappa B proteins of a mouse macrophage-like cell line, J774. , 1993, Cellular signalling.

[24]  D. Morrison,et al.  Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production in mouse peritoneal macrophages. , 1993, Journal of immunology.

[25]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[26]  Fenguangzhai Song.  CD , 1992 .

[27]  L. Stehno-Bittel,et al.  Exercise training depletes sarcoplasmic reticulum calcium in coronary smooth muscle. , 1991, Journal of applied physiology.

[28]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[29]  T. Libermann,et al.  Activation of interleukin-6 gene expression through the NF-kappa B transcription factor , 1990, Molecular and cellular biology.

[30]  S. Rosenberg,et al.  Antitumor activity of recombinant interleukin 6 in mice , 1990, The Journal of experimental medicine.

[31]  K. Mitomo,et al.  Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines , 1990, Molecular and cellular biology.

[32]  B. Strulovici,et al.  Lipopolysaccharide response is linked to the GTP binding protein, Gi2, in the promonocytic cell line U937. , 1989, The Journal of biological chemistry.

[33]  T. Luger,et al.  IFN-beta 2/IL-6 augments the activity of human natural killer cells. , 1989, Journal of immunology.

[34]  A. Waage,et al.  Cytokine regulation of interleukin 6 production by human endothelial cells. , 1989, Cellular immunology.

[35]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[36]  T. Podor,et al.  Human Endothelial Cells Produce IL‐6 , 1989 .

[37]  S. Tatter,et al.  Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. , 1989, Biochemical and biophysical research communications.

[38]  A. Mantovani,et al.  IL-1 stimulates IL-6 production in endothelial cells. , 1989, Journal of immunology.

[39]  T. Hirano,et al.  B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes , 1988, The Journal of experimental medicine.

[40]  P. Lansdorp,et al.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. DeFranco,et al.  Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopolysaccharide. , 1986, Science.

[42]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[43]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.